7V0 Share Price Performance
€7.00
-0.30 (-4.11%)
58.1% undervalued intrinsic discount
€16.70
Fair Value
Price €7.00
Clive_Thompson €16.70
Fair Value€16.70
Share Pricen/a
New Narrative • Sep 06
Novogenia AG Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 5 Fair Values set on narratives written by author
7V0 Community Narratives
CL
Fair Value
·Fair Value €16.7 58.1% undervalued intrinsic discount
Novogenia: A High-Risk, Asset-Backed Micro-Cap With Significant Optionality
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Novogenia
58.1% undervalued intrinsic discount
Novogenia: A High-Risk, Asset-Backed Micro-Cap With Significant Optionality
View narrativeCL
Published 6 Sep
Trending Discussion
No trending discussion available.
Recently Updated Narratives
CL
Novogenia: A High-Risk, Asset-Backed Micro-Cap With Significant Optionality
Fair Value: €16.7 58.1% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Novogenia AG Key Details
About 7V0
- Founded
- 2021
- Employees
- 204
- CEO
- WebsiteView website
Novogenia AG manufactures and sells personalized health products in global markets. The company offers products, such as personalized supplements and cosmetics; and services, including genetic testing, advanced therapies like personalized infusion therapies and reproductive genetics, and contract manufacturing. The company was formerly known as Darwin AG and changed its name to Novogenia AG in June 2026. The company was incorporated in 2021 and is based in Munich, Germany.
